Fig. 7From: Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy| Schematic diagram illustrating the regulation of the IDO-Kyn-AhR pathway and IFN-γ production in T cells by CAI and the proposed signal modulation mediated by T cell activationBack to article page